enVVeno Medical Q2 EPS $(5.37) Up From $(11.55) YoY
enVVeno Medical Corp NVNO
$10.60
▼ -0.25%
($-0.03)
🎈 Low Float
Open
$10.60
Prev Close
$10.63
Day Range
$10.60 – $10.60
52W Range
$8.67 – $184.04
Market Cap
$7.08M
Beta
1.04
EPS (TTM)
$-31.33
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-05-31 |
| Shares Out. | 670,000 |
| Website | envveno.com/ ↗ |
| Phone | 13026365400 |
| Employees | 33 |
| Net Income | -$3.8M |
| Free Cash Flow | -$14.8M |
| Total Assets | $26.1M |
| Total Liabilities | $2.4M |
| Equity | $23.7M |
About enVVeno Medical Corp
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
enVVeno Medical Corp is a publicly traded company under the ticker symbol NVNO on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-07-01)